Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Review challenges the 'static vs cidal' dogma
Data from high-quality, randomized controlled trials show that bactericidal antibiotics are not intrinsically superior to bacteriostatic antibiotics, researchers from the University of Southern California School of Medicine report in a new paper in Clinical Infectious Diseases.
To test the common belief that bactericidal antibiotics (agents that kill or eliminate bacteria) are more effective than bacteriostatic antibiotics (agents that halt bacterial growth), the researchers conducted a systematic review of all randomized controlled trials published from January 1985 through September 2017 that compared clinical outcomes of bactericidal versus bacteriostatic antibiotics when treating serious or life-threatening invasive infections. They identified 56 trials to include in the review.
Of the 56 trials identified, 49 (81%) found no significant difference in efficacy between bacteriostatic and bactericidal agents, including for potentially highly lethal infections, such as typhoid fever, pneumonia, plague, or bacteremia. Furthermore, six of the trials showed that the bacteriostatic agent was more effective than the bactericidal agents.
Only one trial, comparing tigecycline with imipenem for the treatment of ventilator-associated pneumonia, found that a bactericidal agent was superior in efficacy. But pharmacologic analysis of that trial determined that the inferiority of the bacteriostatic agent (tigecycline) was based on the dose being too low; when the dose of tigecycline was doubled, efficacy was similar to imipenem.
The authors of the review say the available data suggest that other drug characteristics, such as optimal dosing, pharmacokinetics, and tissue penetration may be more important drivers of clinical efficacy.
"While it seems intuitive that antibiotics that more rapidly kill bacteria should be more clinically effective, a systematic review of randomized controlled trials does not support this assertion," the authors write. "It is time to abandon the notion that bactericidal agents are intrinsically more effective than bacteriostatic agents."
Dec 26 Clin Infect Dis abstract
Study probes role of portable medical equipment in pathogen spread
A small study conducted at a Veteran's Affairs hospital in Texas suggests that portable medical equipment (PME) could play an important role in the transmission cycle of healthcare-associated infections, researchers from the Texas Veterans Health Care System reported yesterday in BMC Infectious Diseases.
In the study, research staff observed different patient-care events over six different 24-hour periods on six different hospital units. The observers followed one healthcare worker for their entire shift, documenting every time they touched a patient or a surface—including hard surfaces, bedding, and PME such as computers on wheels (COW), vitals machines, and IV infusion pumps. Each encounter was recorded as a sequence of events and analyzed using sequence analysis. The purpose of the study was to investigate the patterns and sequence of touch events among healthcare workers, patients, surfaces, and equipment in the hospital environment.
The most commonly touched items in patient rooms were the patients with 850 touches, COW (634), bedrails (375), and IV pumps. Sequence analysis revealed that touching the patient and then the bedrail was the most common sub-sequence (occurring in 28.1% of all sequences). Touching the COW and then the patient was the most common sub-sequence between PME and patient (22.6% of all sequences), followed by touching the patient and then the COW (20.4% of all sequences), and touching the patient and then the IV pump (16.1% of all sequences).
The researchers also observed that hand hygiene was below expectations and that gloves were used in only about half the encounters. In addition, 5 of 48 COWs (10.4%) were contaminated with methicillin-resistant Staphylococcus aureus.
"PME, particularly COW and IV pump, are highly touched items and were common in sub-sequences that involved the patient, possibly contributing to higher pathogen transmission risk," the authors write. "Disinfection of PME, preferably in between patient interactions, may potentially be necessary, along with optimal hand hygiene, to reduce the possibility of transmission between patients."
Dec 28 BMC Infect Dis study
Study finds steady increase in antibiotic use in Chinese hospitals
Originally published by CIDRAP News Dec 28
Despite efforts to improve antibiotic use, total antibiotic consumption in China's tertiary hospitals showed a significant upward trend from 2011 through 2015, according to a study yesterday in PLoS One.
In the study, investigators from Peking University retrospectively analyzed aggregated monthly surveillance data on antibiotic sales to 468 hospitals in 28 provinces in China over the 5-year period, which coincided with a 3-year national regulatory campaign (2011-2014) to control total antibiotic use in the country's secondary and tertiary hospitals. Antibiotic consumption was expressed in defined daily doses per 1,000 inhabitants per day (DID), and population weighted antibiotic consumption patterns in China were compared with European countries using indicators from the European Surveillance of Antimicrobial Consumption (ESAC).
Total antibiotic consumption, including all specific antibiotic classes except macrolides, significantly climbed over the study period, from an average of 7.97 DID in 2011 to 10.08 DID in 2015. The most frequently used antibiotics were cephalosporins, which accounted for 28.6% of total consumption, followed beta-lactam-beta-lactamase inhibitor combinations (20%), macrolides (17.4%), and fluoroquinolones (10.5%). Antibiotics in parenteral form accounted for nearly half of all antibiotics consumed.
Analysis of regional distribution of antibiotic consumption showed that eastern regions of the country used more antibiotics than western regions when using census population as a denominator. Comparison of antibiotic use in China with ESAC data from 2012 showed that there was higher consumption of third- and fourth-generation cephalosporins and fluoroquinolones in China than in 75% of the 29 European countries.
The authors of the study say more research is needed on the appropriateness of antibiotic prescriptions in Chinese hospitals to help reduce the risk of antibiotic resistance. China is estimated to be the second largest consumer of antibiotics in the world.
Dec 27 PLoS One study